Author:
Suh Koung Jin,Yoon Seonghae,Kim Jin Won,Yoon Seo Hyun,Kim Ji-Won,Kim Se Hyun,Kim Yu Jung,Lee Keun-Wook,Lee Jong Seok,Kim Jee Hyun
Funder
Seoul National University Bundang Hospital
Subject
Geriatrics and Gerontology,Oncology
Reference31 articles.
1. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment;Bloechl-Daum;J Clin Oncol,2006
2. NCCN clinical practice guidelines in oncology (NCCN guidelines®);National Comprehensive Cancer Network,2020
3. Randomized, double-blind, dose-finding study of dexamethasone in preventing acute emesis induced by anthracyclines, carboplatin, or cyclophosphamide;Italian Group For Antiemetic Research;J Clin Oncol,2004
4. Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy;Aapro;Ann Oncol,2010
5. Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial;Celio;Support Care Cancer,2011
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献